Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Explore clinical trials studying Chronic Myelogenous Leukemia, BCR-ABL1 Positive. Study availability and eligibility vary by location and protocol.

32 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Chronic Myelogenous Leukemia, BCR-ABL1 Positive trial results

Completed

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML

NCT00702403

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Blast Crisis, +36 more
Locations
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium Tampa, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details
Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

NCT00351975

Conditions
Accelerated Phase of Disease, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +47 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
  • Princess Margaret Hospital Cashmere, Canterbury, New Zealand
View Trial Details
Completed

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

NCT00060372

Conditions
Adnexal Diseases, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +148 more
Locations
  • Scripps Clinic - La Jolla La Jolla, California, United States
  • University of California San Diego La Jolla, California, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Northside Hospital Atlanta, Georgia, United States
View Trial Details

Related conditions